GRI BIO, INC.
Income Statement
| Line Item | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $1.3M | $2.0M | $215.0K | $1.2M | $1.8M | $1.3M | $733.0K | $808.0K |
| SG&A Expense | $1.4M | $1.1M | $1.0M | $1.1M | $830.0K | $179.0K | $300.0K | $327.0K |
| Operating Income | $-2.6M | $-3.1M | $-1.3M | $-2.3M | $-2.6M | $-1.5M | $-1.0M | $-1.1M |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | $0 | — | — | — |
| Net Income | $-302.0K | $-3.1M | $-1.3M | $-2.3M | $-2.6M | $-1.5M | $-1.0M | $-1.1M |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | $-0.19 | $-0.01 | $0.00 | $-0.01 | $-0.01 | $-0.01 | $0.00 | $0.00 |
| EPS (Diluted) | $-0.19 | $-0.01 | $0.00 | $-0.01 | $-0.01 | $-0.01 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 13.6M | 392.5M | 408.8M | 408.8M | 342.6M | 270.4M | 270.4M | 270.4M |
| Shares Outstanding (Diluted) | 13.6M | 392.5M | 408.8M | 408.8M | 342.6M | 270.4M | 270.4M | 270.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |